Innate and acquired immunity in atherogenesis - PubMed (original) (raw)

Review

. 2002 Nov;8(11):1218-26.

doi: 10.1038/nm1102-1218.

Affiliations

• PMID: 12411948
• DOI: 10.1038/nm1102-1218

Review

Innate and acquired immunity in atherogenesis

Christoph J Binder et al. Nat Med. 2002 Nov.

No abstract available

PubMed Disclaimer

Comment in

• Humoral immunity and atherosclerosis.
  Virella G, Lopes-Virella MF. Virella G, et al. Nat Med. 2003 Mar;9(3):243-4; author reply 244-5. doi: 10.1038/nm0303-243. Nat Med. 2003. PMID: 12612552 No abstract available.

Similar articles

• Autoimmunity: busting the atherosclerotic plaque.
  Rose N, Afanasyeva M. Rose N, et al. Nat Med. 2003 Jun;9(6):641-2. doi: 10.1038/nm0603-641. Nat Med. 2003. PMID: 12778153 No abstract available.
• Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL.
  Binder CJ, Hörkkö S, Dewan A, Chang MK, Kieu EP, Goodyear CS, Shaw PX, Palinski W, Witztum JL, Silverman GJ. Binder CJ, et al. Nat Med. 2003 Jun;9(6):736-43. doi: 10.1038/nm876. Epub 2003 May 12. Nat Med. 2003. PMID: 12740573
• Humoral immunity and atherosclerosis.
  Virella G, Lopes-Virella MF. Virella G, et al. Nat Med. 2003 Mar;9(3):243-4; author reply 244-5. doi: 10.1038/nm0303-243. Nat Med. 2003. PMID: 12612552 No abstract available.
• Rethinking oxidized low-density lipoprotein, its role in atherogenesis and the immune responses associated with it.
  Shaw PX. Shaw PX. Arch Immunol Ther Exp (Warsz). 2004 Jul-Aug;52(4):225-39. Arch Immunol Ther Exp (Warsz). 2004. PMID: 15467487 Review.
• IL-5 links adaptive and natural immunity in reducing atherosclerotic disease.
  Daugherty A, Rateri DL, King VL. Daugherty A, et al. J Clin Invest. 2004 Aug;114(3):317-9. doi: 10.1172/JCI22561. J Clin Invest. 2004. PMID: 15286796 Free PMC article. Review.

Cited by

• Emerging role of sphingolipids and extracellular vesicles in development and therapeutics of cardiovascular diseases.
  Bhat OM, Mir RA, Nehvi IB, Wani NA, Dar AH, Zargar MA. Bhat OM, et al. Int J Cardiol Heart Vasc. 2024 Jul 23;53:101469. doi: 10.1016/j.ijcha.2024.101469. eCollection 2024 Aug. Int J Cardiol Heart Vasc. 2024. PMID: 39139609 Free PMC article. Review.
• Tipping the Scale: Atheroprotective IgM-Producing B Cells in Atherosclerosis.
  Ransegnola BP, Pattarabanjird T, McNamara CA. Ransegnola BP, et al. Arterioscler Thromb Vasc Biol. 2024 Sep;44(9):1906-1915. doi: 10.1161/ATVBAHA.124.319847. Epub 2024 Jul 18. Arterioscler Thromb Vasc Biol. 2024. PMID: 39022832 Review.
• Endothelial exosomes work as a functional mediator to activate macrophages.
  Lin W, Huang F, Yuan Y, Li Q, Lin Z, Zhu W, Lin B, Zhu P. Lin W, et al. Front Immunol. 2023 Jul 28;14:1169471. doi: 10.3389/fimmu.2023.1169471. eCollection 2023. Front Immunol. 2023. PMID: 37575264 Free PMC article.
• A Framework for Understanding Maternal Immunity.
  Bonney EA. Bonney EA. Immunol Allergy Clin North Am. 2023 Feb;43(1S):e1-e20. doi: 10.1016/j.iac.2023.03.002. Epub 2023 Apr 15. Immunol Allergy Clin North Am. 2023. PMID: 37179052 Free PMC article. Review.
• IgG1 Is the Optimal Subtype for Treating Atherosclerosis by Inducing M2 Macrophage Differentiation, and Is Independent of the FcγRIIA Gene Polymorphism.
  Duan R, Liu Y, Tang D, Lin R, Huang J, Zhao M. Duan R, et al. Int J Mol Sci. 2023 Mar 21;24(6):5932. doi: 10.3390/ijms24065932. Int J Mol Sci. 2023. PMID: 36983007 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database